A sponsored analysis from Fierce Pharma argues that pharma marketers are underusing artificial intelligence. So far, the piece contends, most applications treat AI as a way to make better individual decisions—comparable to checking a box score after a game. The real opportunity, it says, lies in building learning systems that improve with every outcome.
Instead of treating each campaign as a one-off event, these systems would create a continuous feedback loop. Every result, whether a success or a miss, becomes input for the next decision. That allows marketing to become more precise, responsive, and self-correcting over time.
The piece frames this as a necessary evolution for an industry that has been cautious with data. Moving beyond the box score means embracing AI not as a tool for occasional insight but as a permanent part of how marketing learns and adapts. The analysis is based on a single sponsored source, so it reflects that perspective rather than a broader industry survey.